Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 90, 180, 360.... CR% the same.

<< Previous

Bullboard Posts

Next >>

Comment by socksnblonds642on Nov 01, 2021 8:36am

570 Views

Post# 34072091

RE:RE:RE:90, 180, 360.... CR% the same.

Yup that 730 day+++ is the most exciting news. Those two patients appear to be cured. If the cancer ever does reappear or a patient has a more aggressive type then they get another treatment. Maybe they have ten treatments over over thirty years, maybe just one. As you say we are looking at the cure for cancer here. So far the numbers point very strongly towards that. Early days though. Next NR, when ready, will be telling. It still may not move the Stock price till they get BTD though.

<< Previous

Bullboard Posts

Next >>

Umicore hits pause on Canadian battery materials plant construction